—
AI-generated
PetVivo Holdings, Inc., a biomedical device company, engages in the manufacturing, commercializing, and licensing of medical devices and biomaterials for the treatment of afflictions and diseases i...
Revenue breakdown: Product (62.5%), Sales To Vedco (17.1%), Sales To Clipper (11.5%).
—Mkt Cap
—Rev TTM
—NI TTM
Latest Earnings
10-Q
Q3 FY2026Feb 16, 2026PetVivo Holdings, Inc. reported a net loss of $2.2 million for Q3 2026 (period ending December 31, 2025), consistent with an operating loss of $2.2 million. Revenue for the quarter was $286 thousand, generating a gross profit of $145 thousand with a gross margin of 50.7%. Operating expenses totaled $2.3 million, dominated by General and Administrative ($1.3 million), Sales and...
What Changed Recently
Fundamentals
How The Business Makes Money
Revenue by Segment
Product62.5%($1M)
Sales To Vedco17.1%($288.9K)
Sales To Clipper11.5%($194.5K)
Sales To Convetrus8.9%($149.7K)
Analyst View
Company Profile
CIK0001512922
ISINUS7168174081
CUSIP716817408
Phone952 405 6216
Address5251 Edina Industrial Boulevard, Minneapolis, MN, 55439, US
SEC EDGAR